Educational Funding of The South Inc. Bonds Series 2007-1 Assigned Preliminary Ratings

  • ID: 1784777
  • October 2007
  • Standard & Poors
1 of 3

NEW YORK (Standard & Poor's) Oct. 8, 2007--Standard & Poor's Ratings Services today assigned its preliminary ratings to Educational Funding of The South Inc. 's (the Corporation) $1.635 billion student loan-backed bonds series 2007-1 (see list). The preliminary ratings are based on information as of Oct. 8, 2007. Subsequent information may result in the assignment of final ratings that differ from the preliminary ratings. The preliminary ratings assigned to the class A-1 through A-10 student loan-backed senior bonds series 2007-1 reflect the approximately 3.02% subordination of the class B bonds and the previously issued class C bonds series 2003Fl, 2004FL, and 2005FL; the fully funded 0.88% reserve account; and the excess spread. The preliminary rating assigned to the subordinate class...

Companies mentioned in this report are: Educational Funding of the South Inc
Action: Preliminary Rating

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research type: News
This product is a is a brief one-page announcement of no more than 500 words with a quote from the analyst. It is media and investor focused with no accompanying commentary article.

Note: Product cover images may vary from those shown
2 of 3

Educational Funding of the South Inc

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown




Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.